Ardena News and Activities

View the org chart displaying its 13 main executives

Most searched biographies at Ardena

• Jeremie Trochu, Chief Executive Officer
• Ariette Van Strien, Non-Executive Chairman of the Board
• Sabina Ouimet-Storrs, Non-Executive Director

Popular executive movements at Ardena

• Ariane De Ganck, who was Division Head, Drug Product Services, is promoted to Chief Scientific Officer  (posted on June 4 2026).
• Henny Zijlstra has joined the company as Chief Commercial Officer  (posted on May 7 2026).
• Ben Ash has joined the company as Chief Financial Officer  (posted on May 7 2026).

Create your alert
to follow the executive moves at Ardena.

Ardena has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Ardena

• Ardena and CHDR Mark 15 Years of Strategic Partnership in Early Phase Drug Development 

Social media about Ardena

• Ardena on Wikipedia, Google News & Yahoo Finance
• Ardena on LinkedIn, X (Twitter) & YouTube